That includes other FDA-approved medications for weight management, as well as structured We also expect that over time these medications will become more affordable and coverage should expand over time
GLP-1 is a naturally occurring hormone produced in the small intestine
Wegovy (semaglutide) represents a shift in how we treat obesity
This is not a unique phenomenon to GLP-1 medications and is similar to what we observe with medications that treat other chronic conditions, like high blood pressure, asthma, or inflammatory bowel disease, Maselli says
People on GLP-1 medications should talk with their doctor to learn ways to manage side effects
Unexpected cardiovascular risks of glucagon-like peptide-1 receptor agonist and aspirin co-administration in individuals with obesity, with and without type 2 diabetes: a propensity score matched cohort study